BACKGROUND: The effects of maternal depression on neonatal neurodevelopment in MA exposed neonates have not been well characterized. OBJECTIVE: To determine the neurobehavioral effects of maternal depressive symptoms on neonates exposed and not exposed to methamphetamine (MA) using the NICU Network Neurobehavioral Scale (NNNS). DESIGN: The purpose of the IDEAL study is to determine the effects of prenatal MA exposure on child outcome. IDEAL screened 13,808 subjects, 1632 were eligible and consented and 176 mothers were enrolled. Only biological mothers with custody of their child at the one-month visit (n=50 MA; n=86 comparison) had the Addiction Severity Index (ASI) administered. The NNNS was administered to the neonate by an examiner blinded to MA exposure within the first five days of life. General Linear Models tested the effects of maternal depression and prenatal MA exposure on NNNS outcomes, with and without covariates. Significance was accepted at p<.05. RESULTS: After adjusting for covariates, regardless of exposure status, maternal depressive symptoms were associated with lower handling and arousal scores, elevated physiological stress scores and an increased incidence of hypotonicity. When adjusting for covariates, MA exposure was associated with lower arousal and higher lethargy scores. CONCLUSIONS: Maternal depressive symptoms are associated with neurodevelopmental patterns of decreased arousal and increased stress. Prenatal MA exposure combined with maternal depression was not associated with any additional neonatal neurodevelopmental differences.
BACKGROUND: The effects of maternal depression on neonatal neurodevelopment in MA exposed neonates have not been well characterized. OBJECTIVE: To determine the neurobehavioral effects of maternal depressive symptoms on neonates exposed and not exposed to methamphetamine (MA) using the NICU Network Neurobehavioral Scale (NNNS). DESIGN: The purpose of the IDEAL study is to determine the effects of prenatal MA exposure on child outcome. IDEAL screened 13,808 subjects, 1632 were eligible and consented and 176 mothers were enrolled. Only biological mothers with custody of their child at the one-month visit (n=50 MA; n=86 comparison) had the Addiction Severity Index (ASI) administered. The NNNS was administered to the neonate by an examiner blinded to MA exposure within the first five days of life. General Linear Models tested the effects of maternal depression and prenatal MA exposure on NNNS outcomes, with and without covariates. Significance was accepted at p<.05. RESULTS: After adjusting for covariates, regardless of exposure status, maternal depressive symptoms were associated with lower handling and arousal scores, elevated physiological stress scores and an increased incidence of hypotonicity. When adjusting for covariates, MA exposure was associated with lower arousal and higher lethargy scores. CONCLUSIONS:Maternal depressive symptoms are associated with neurodevelopmental patterns of decreased arousal and increased stress. Prenatal MA exposure combined with maternal depression was not associated with any additional neonatal neurodevelopmental differences.
Authors: Chris Derauf; Linda LaGasse; Lynne Smith; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne Dansereau; Hai Lin; Barry Lester Journal: J Dev Behav Pediatr Date: 2011 Feb-Mar Impact factor: 2.225
Authors: Katherine Sorsdahl; Petal Petersen Williams; Kathy Everett-Murphy; Bavi Vythilingum; Patricia de Villiers; Bronwyn Myers; Dan J Stein Journal: Community Ment Health J Date: 2015-03-06
Authors: Zeina N Kiblawi; Lynne M Smith; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn Huestis; Sheri DellaGrotta; Lynne M Dansereau; Charles Neal; Barry Lester Journal: J Dev Behav Pediatr Date: 2013-01 Impact factor: 2.225
Authors: Lynne M Smith; Monica S Paz; Linda L LaGasse; Chris Derauf; Elana Newman; Rizwan Shah; Amelia Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester Journal: Depress Anxiety Date: 2012-05-03 Impact factor: 6.505
Authors: Brandi D Liles; Elana Newman; Linda L Lagasse; Chris Derauf; Rizwan Shah; Lynne M Smith; Amelia M Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Dellagrotta; Lynne M Dansereau; Charles Neal; Barry M Lester Journal: Child Psychiatry Hum Dev Date: 2012-12
Authors: Kimberly Yolton; Jane Khoury; Yingying Xu; Paul Succop; Bruce Lanphear; John T Bernert; Barry Lester Journal: Neurotoxicol Teratol Date: 2009-07-17 Impact factor: 3.763
Authors: Lynne M Smith; Sabrina Diaz; Linda L LaGasse; Trecia Wouldes; Chris Derauf; Elana Newman; Amelia Arria; Marilyn A Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M Dansereau; Charles Neal; Barry M Lester Journal: Neurotoxicol Teratol Date: 2015-07-23 Impact factor: 3.763